Evidence map›Paper›PMID 33573016›Full record

ArticleToxins2021

Ricin Antibodies' Neutralizing Capacity against Different Ricin Isoforms and Cultivars.

Maria Lucia Orsini Delgado, Arnaud Avril, Julie Prigent, Julie Dano, Audrey Rouaix, Sylvia Worbs, Brigitte G Dorner, Clémence Rougeaux, François Becher, François Fenaille and 4 more

Abstract readComparative Study
In one paragraph

Article in Toxins, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Search for Antidotes Against Ricin.Mini reviews in medicinal chemistry · 2024
    Review
  11. Article
  12. Review
  13. Article
  14. Introduction to theToxins · 2022
    Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Maria Lucia Orsini DelgadoParis-Saclay University, CEA, INRAE, Medicines and Healthcare Technologies Department (DMTS), SPI, 91191 Gif-sur-Yvette, France.
Arnaud AvrilMicrobiology and Infectious Diseases Department, Anti-Infectious Biotherapies and Immunity Unit, Army Biomedical Research Institute, 91220 Brétigny-sur-Orge, France.
Julie PrigentParis-Saclay University, CEA, INRAE, Medicines and Healthcare Technologies Department (DMTS), SPI, 91191 Gif-sur-Yvette, France.
Julie DanoParis-Saclay University, CEA, INRAE, Medicines and Healthcare Technologies Department (DMTS), SPI, 91191 Gif-sur-Yvette, France.
Audrey RouaixParis-Saclay University, CEA, INRAE, Medicines and Healthcare Technologies Department (DMTS), SPI, 91191 Gif-sur-Yvette, France.
Sylvia WorbsBiological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute (RKI), 13353 Berlin, Germany.
Brigitte G DornerBiological Toxins, Centre for Biological Threats and Special Pathogens, Robert Koch Institute (RKI), 13353 Berlin, Germany.ORCID 0000-0002-5100-2546
Clémence RougeauxMicrobiology and Infectious Diseases Department, Anti-Infectious Biotherapies and Immunity Unit, Army Biomedical Research Institute, 91220 Brétigny-sur-Orge, France.
François BecherParis-Saclay University, CEA, INRAE, Medicines and Healthcare Technologies Department (DMTS), SPI, 91191 Gif-sur-Yvette, France.ORCID 0000-0002-1075-9980
François FenailleParis-Saclay University, CEA, INRAE, Medicines and Healthcare Technologies Department (DMTS), SPI, 91191 Gif-sur-Yvette, France.ORCID 0000-0001-6787-4149
Sandrine LivetParis-Saclay University, CEA, INRAE, Medicines and Healthcare Technologies Department (DMTS), SPI, 91191 Gif-sur-Yvette, France.ORCID 0000-0001-7966-5379
Hervé VollandParis-Saclay University, CEA, INRAE, Medicines and Healthcare Technologies Department (DMTS), SPI, 91191 Gif-sur-Yvette, France.
Jean-Nicolas TournierMicrobiology and Infectious Diseases Department, Anti-Infectious Biotherapies and Immunity Unit, Army Biomedical Research Institute, 91220 Brétigny-sur-Orge, France.ORCID 0000-0002-4542-2421
Stéphanie SimonParis-Saclay University, CEA, INRAE, Medicines and Healthcare Technologies Department (DMTS), SPI, 91191 Gif-sur-Yvette, France.ORCID 0000-0002-6071-8255

Funding

French joint ministerial program of R&D against CBRNE threats I14
6 · The paper itself

Abstract

Ricin, a highly toxic protein from

Indexed as

AnimalsAntibodies, NeutralizingAntibody SpecificityAntidotesCell SurvivalDrug Therapy, CombinationFemaleHumansJurkat CellsLethal Dose 50MiceMice, Inbred BALB CPoisoningProtein IsoformsRicinRicinusAntibodies, NeutralizingAntidotesProtein IsoformsRicinmonoclonal antibodiesmouse modelneutralizing antibodiespulmonary intoxicationrecombinant antibodiesricinricin isoformsRicinus communis cultivarstreatment

Identifiers

PMID33573016
PMCPMC7911099

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.